Benign Effusions

  • Pınar FıratEmail author


Serous cavities of the body – the peritoneal cavity, the pericardial cavity and the two pleural cavities – are closed spaces covered by the parietal and visceral layers of serous membranes. Under physiologic conditions, the two layers of the serous membranes are in close apposition, and only a small amount of fluid is present within the cavities, acting as a lubricant between the parietal and visceral layers to prevent friction. Accumulation of fluid in the serous cavities is called “effusion”. Any serous effusion is considered to be pathologic irrespective of the cause and the content of the accumulated fluid.1,2


Pleural Effusion Mesothelial Cell Malignant Mesothelioma Psammoma Body Serous Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Shidham VB. Introduction. In: Shidham VB, Atkinson BF, eds. Cytopathologic Diagnosis of Serous Fluids. Chap. 1. Philadelphia: Saunders Elsevier; 2007:1–17.Google Scholar
  2. 2.
    Tao LC. Etiology of effusions. In: Tao LC, ed. Cytopathology of Malignant Effusions. Johnston WW series ed. ASCP Theory and practice of cytopathology. Vol 6. Chap. 1. Chicago: ASCP Press; 1996:1–55.Google Scholar
  3. 3.
    Sahn SA. The value of pleural fluid analysis. Am J Med Sci. 2008;335:7-15.PubMedCrossRefGoogle Scholar
  4. 4.
    Wong JW, Pitlik D, Abdul-Karim FW. Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary. Acta Cytol. 1997;41:467-473.PubMedCrossRefGoogle Scholar
  5. 5.
    DeMay RM. Fluids. In: DeMay RM, ed. The Art and Science of Cytopathology. Vol I. Chap. 8. Chicago: ASCP Press; 1996:257–325Google Scholar
  6. 6.
    Porcel JM. Pearls and myths in pleural fluid analysis. Respirology. 2011;16:44-52.PubMedCrossRefGoogle Scholar
  7. 7.
    Heffner JE. Discriminating between transudates and exudates. Clin Chest Med. 2006;27:241-252.PubMedCrossRefGoogle Scholar
  8. 8.
    Yousef MM, Michael CW. Body cavity fluids. In: Gattuso P, Reddy VB, Masood S, eds. Differential Diagnosis in Cytopathology. Chap. 3. New York: Cambridge University Press; 2010:99–150.Google Scholar
  9. 9.
    Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507-513.PubMedGoogle Scholar
  10. 10.
    Romero-Candeira S, Hernandez L. The separation of transudates and exudates with particular reference to the protein gradient. Curr Opin Pulm Med. 2004;10:294-298.PubMedCrossRefGoogle Scholar
  11. 11.
    Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med. 2010;31:743-750.PubMedCrossRefGoogle Scholar
  12. 12.
    Light RW. Update on tuberculous pleural effusion. Respirology. 2010;15:451-458.PubMedCrossRefGoogle Scholar
  13. 13.
    Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single center experience with over 2100 consecutive patients. Eur J Intern Med. 2010;21:419-423.PubMedCrossRefGoogle Scholar
  14. 14.
    Antony VB, Godbey SW, Kunkel SL, et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol. 1993;151:7216-7223.PubMedGoogle Scholar
  15. 15.
    Sherr HP, Light RW, Merson MH, Wolf RO, Taylor LL, Hendrix TR. Origin of pleural fluid amylase in esophageal rupture. Ann Intern Med. 1972;76:985-986.PubMedGoogle Scholar
  16. 16.
    Kramer MR, Saldana MJ, Cepero RJ, Pitchenik AE. High amylase levels in neoplasm-related pleural effusion. Ann Intern Med. 1989;110:567-569.PubMedGoogle Scholar
  17. 17.
    Villena V, López-Encuentra A, García-Luján R, Echave-Sustaeta J, Martínez CJ. Clinical implications of appearance of pleural fluid at thoracentesis. Chest. 2004;125:156-159.PubMedCrossRefGoogle Scholar
  18. 18.
    Light RW. Clinical practice. Pleural effusion. N Engl J Med. 2002;346:1971-1977.PubMedCrossRefGoogle Scholar
  19. 19.
    Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc. 2009;84:129-133.PubMedCrossRefGoogle Scholar
  20. 20.
    Pereira TC, Saad RS, Liu Y, Silverman JF. The diagnosis of malignancy in effusion cytology: a pattern recognition approach. Adv Anat Pathol. 2006;13:174-184.PubMedCrossRefGoogle Scholar
  21. 21.
    Stevens MW, Leong ASY, Fazzalari NL, Dowling KD, Henderson DW. Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol. 1992;8:333-341.PubMedCrossRefGoogle Scholar
  22. 22.
    Boerner SL. Mimicry and pitfalls in effusion cytology. Pathology Case Rev. 2006; 11: 85-91.Google Scholar
  23. 23.
    Gordon HY, Sack MJ, Baloch ZW, DeFrias DVS, Gupta PK. Occurrence of intercellular spaces (Windows) in metastatic adenocarcinoma in serous fluids: a cytomorphologic, histochemical and ultrastuctural study. Diagn Cytopathol. 1999;20:115-119.CrossRefGoogle Scholar
  24. 24.
    Selvaggi SM. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol. 2003;28:335-341.PubMedCrossRefGoogle Scholar
  25. 25.
    Bedrossian CWM. Diagnostic problems in serous effusions. Diagn Cytopathol. 1998;19:131-137.PubMedCrossRefGoogle Scholar
  26. 26.
    Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol. 2007;38:1-16.PubMedCrossRefGoogle Scholar
  27. 27.
    Metzgeroth G, Kuhn C, Schultheis B, Hehlmann R, Hastka J. Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions. Cytopathology. 2008;19:205-211.PubMedCrossRefGoogle Scholar
  28. 28.
    Grefte JM, de Wilde PC, de Pol MR Salet-van, Tomassen M, Raaymakers-van Geloof WL, Bulten J. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions. Acta Cytol. 2008;52:35-44.PubMedCrossRefGoogle Scholar
  29. 29.
    Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol. 2006;34:335-347.PubMedCrossRefGoogle Scholar
  30. 30.
    Valdes L, Alvarez D, Valle JM, Pose A, Jose ES. The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest. 1996;109:158-162.PubMedCrossRefGoogle Scholar
  31. 31.
    Hampson C, Lemos JA, Klein JS. Diagnosis and management of parapneumonic effusions. Semin Respir Crit Care Med. 2008;29:414-426.PubMedCrossRefGoogle Scholar
  32. 32.
    Cugell DW, Kamp DW. Asbestos and the pleura. Chest. 2004;125:1103-1117.PubMedCrossRefGoogle Scholar
  33. 33.
    Krenke R, Nasilowski J, Korczynski P, et al. Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J. 2009;34:1111-1117.PubMedCrossRefGoogle Scholar
  34. 34.
    Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest. 1996;110:1271-1274.PubMedCrossRefGoogle Scholar
  35. 35.
    Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med. 1984;77:915-920.PubMedCrossRefGoogle Scholar
  36. 36.
    Krishnan S, Statsinger AL, Kleinman M, Bertoni MA, Sharma P. Eosinophilic pleural effusion with Charcot-Leyden crystals. Acta Cytol. 1983;27:529-532.PubMedGoogle Scholar
  37. 37.
    Kumar NB, Naylor B. Megakaryocytes in pleural and peritoneal fluids: prevalence, significance, morphology and cytohistological correlation. J Clin Pathol. 1980;33:1153-1159.PubMedCrossRefGoogle Scholar
  38. 38.
    Bowling MR, Cauthen CG, Perry CD, et al. Pulmonary extramedullary hematopoiesis. J Thorac Imaging. 2008;23:138-141.PubMedCrossRefGoogle Scholar
  39. 39.
    Kobayashi TK, Moritani S, Urabe M, et al. Cytologic diagnosis of endosalpingiosis with pregnant women presenting in peritoneal fluid: a case report. Diagn Cytopathol. 2004;30:422-425.PubMedCrossRefGoogle Scholar
  40. 40.
    Kuritzkes DR, Rein M, Horowitz S, et al. Detached ciliary tufts mistaken for peritoneal parasites: a warning. Rev Infect Dis. 1988;10:1044-1047.PubMedCrossRefGoogle Scholar
  41. 41.
    Sidawy MK, Chandra P, Oertel YC. Detached ciliary tufts in female peritoneal washings. A common finding. Acta Cytol. 1987;31:841-844.PubMedGoogle Scholar
  42. 42.
    Risberg B, Davidson B, Dong HP, Nesland JM, Berner A. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings. J Clin Pathol. 2000;53:513-517.PubMedCrossRefGoogle Scholar
  43. 43.
    Shield P. Peritoneal washing cytology. Cytopathology. 2004;15:131-141.PubMedCrossRefGoogle Scholar
  44. 44.
    Parwani AV, Chan TY, Ali SZ. Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis. Cancer. 2004;102:87-91.PubMedCrossRefGoogle Scholar
  45. 45.
    Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci. 2009;338:211-216.PubMedCrossRefGoogle Scholar
  46. 46.
    Porcel JM. Pleural effusions from congestive heart failure. Semin Respir Crit Care Med. 2010;31:689-697.PubMedCrossRefGoogle Scholar
  47. 47.
    Berger HW, Rammohan G, Neff MS, Buhain WJ. Uremic pleural effusion. Ann Intern Med. 1975;82:362-364.PubMedGoogle Scholar
  48. 48.
    Piraino B, Sheth H. Peritonitis - Does peritoneal dialysis modality make a difference? Blood Purif. 2010;29:145-149.PubMedCrossRefGoogle Scholar
  49. 49.
    Ejaz AA, Fitzpatrick PM, Durkin AJ, et al. Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients. Nephron. 1999;81:125-130.PubMedCrossRefGoogle Scholar
  50. 50.
    Han SH, Reynolds TB, Fong TL. Nephrogenic ascites. Analysis of 16 cases and review of the literature. Medicine (Baltimore). 1998;77:233-245.CrossRefGoogle Scholar
  51. 51.
    Browne GW, Pitchumoni CS. Pathophysiology of pulmonary complications of acute pancreatitis. World J Gastroenterol. 2006;12:7087-7096.PubMedGoogle Scholar
  52. 52.
    Pai CG, Suvarna D, Bhat G. Endoscopic treatment as first-line therapy for pancreatic ascites and pleural effusion. J Gastroenterol Hepatol. 2009;24:1198-1202.PubMedCrossRefGoogle Scholar
  53. 53.
    Light RW. Pleural effusion in pulmonary embolism. Semin Respir Crit Care Med. 2010;31:716-722.PubMedCrossRefGoogle Scholar
  54. 54.
    Baumann MH, Nolan R, Petrini M, Lee YC, Light RW, Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest. 2007;131:1125-1132.PubMedCrossRefGoogle Scholar
  55. 55.
    Trajman A, Kaisermann C, Luiz RR, et al. Pleural fluid ADA, IgA-ELISA and PCR sensitivities for the diagnosis of pleural tuberculosis. Scand J Clin Lab Invest. 2007;67:877-884.PubMedCrossRefGoogle Scholar
  56. 56.
    Ellison E, Lapuerta P, Martin SE. Cytologic features of Mycobacterial pleuritis: logistic regression and statistical analysis of a blinded, case-controlled study. Diagn Cytopathol. 1998;19:173-176.PubMedCrossRefGoogle Scholar
  57. 57.
    Lau KY. Numerous mesothelial cells in tuberculous pleural effusions. Chest. 1989;96:438-439.PubMedCrossRefGoogle Scholar
  58. 58.
    Chou CW, Chang SC. Pleuritis as a presenting manifestation of rheumatoid arthritis: diagnostic clues in pleural fluid cytology. Am J Med Sci. 2002;323:158-161.PubMedCrossRefGoogle Scholar
  59. 59.
    Avnon LS, Abu-Shakra M, Flusser D, Heimer D, Sion-Vardy N. Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate? Rheumatol Int. 2007;27:919-925.PubMedCrossRefGoogle Scholar
  60. 60.
    Naylor B. The pathognomonic cytologic picture of rheumatoid pleuritis. Acta Cytol. 1990;34:465-473.PubMedGoogle Scholar
  61. 61.
    Brucato A, Tombini V, Guffanti C. Clinical image: comet cells in rheumatoid arthritis. Arthritis Rheum. 2006;54:243.PubMedCrossRefGoogle Scholar
  62. 62.
    Ishiguro N, Tomino Y, Fujito K, Nakayama S, Koide H. A case of massive ascites due to lupus peritonitis with a dramatic response to steroid pulse therapy. Jpn J Med. 1989;28:608-611.PubMedCrossRefGoogle Scholar
  63. 63.
    Ruiz-Argüelles A, Alarcón-Segovia D. Novel facts about an old marker: the LE cell. Scand J Clin Lab Invest Suppl. 2001;235:31-37.PubMedGoogle Scholar
  64. 64.
    Reda MG, Baigelman W. Pleural effusion in systemic lupus erythematosus. Acta Cytol. 1980;24:553-557.PubMedGoogle Scholar
  65. 65.
    Wang DY, Chang DB, Kuo SH, et al. Systemic lupus erythematosus presenting as pleural effusion: report of a case. J Formos Med Assoc. 1995;94:746-749.PubMedGoogle Scholar
  66. 66.
    Park JY, Malik A, Dumoff KL, Gupta PK. Case report and review of lupus erythematosus cells in cytology fluids. Diagn Cytopathol. 2007;35:806-809.PubMedCrossRefGoogle Scholar
  67. 67.
    de Torres EF, Guevara EC. Pleuritis by radiation: report of two cases. Acta Cytol. 1981;25:427-429.Google Scholar
  68. 68.
    von Haam. The effect of chemotherapy and radiotherapy upon the cells of transudates and exudates. Monogr Clin Cytol. 1977;5:93–123.Google Scholar
  69. 69.
    Wojno KJ, Olson JL, Sherman ME. Cytopathology of pleural effusions after radiotherapy. Acta Cytol. 1994;38:1-8.PubMedGoogle Scholar
  70. 70.
    Zhu W, Michael CW. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn Cytopathol. 2007;35:370-375.PubMedCrossRefGoogle Scholar
  71. 71.
    Pomjanski N, Grote HJ, Doganay P, Schmiemann V, Buckstegge B, Böcking A. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Diagn Cytopathol. 2005;33:309-315.PubMedCrossRefGoogle Scholar
  72. 72.
    Pu RT, Pang Y, Michael CW. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol. 2008;36:20-25.PubMedCrossRefGoogle Scholar
  73. 73.
    Westfall DE, Fan X, Marchevsky AM. Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol. 2010;38:9-14.PubMedGoogle Scholar
  74. 74.
    Whitaker D. Cytopathology of malignant mesothelioma. Cytopathology. 2000;11:139-151.PubMedCrossRefGoogle Scholar
  75. 75.
    Davidson B, Nielsen S, Christensen J, et al. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol. 2001;25:1405-1412.PubMedCrossRefGoogle Scholar
  76. 76.
    Saad RS, Cho P, Liu YL, Silverman JF. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma. Diagn Cytopathol. 2005;32:156-159.PubMedCrossRefGoogle Scholar
  77. 77.
    Kitazume H, Kitamura K, Mukai K, et al. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining. Cancer. 2000;90:55-60.PubMedCrossRefGoogle Scholar
  78. 78.
    Hasteh F, Grace YL, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:90-96.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Department of Pathology, İstanbul Faculty of Medicineİstanbul UniversityİstanbulTurkey

Personalised recommendations